ORPHA:85414
Systemic-onset juvenile idiopathic arthritis
Also known as: Still disease · Systemic-onset JIA
Publications
3,163
90.2th percentile
Trials
8
Interventional, condition-specific
Researchers
1,122
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare pediatric rheumatological disease characterized by the variable occurrence of chronic arthritis, intermittent high spiking fever, maculopapular rash during fever episodes, and/or , lymphadenopathy, and serositis.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019434
- MeSH:C565798
- UMLS:C1858558
- NCIT:C119031
Additional Mondo synonyms (4)
SoJIA · sJIA · systemic polyarthritis · systemic-onset JIA
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,163 matched papers (1,801 in last 10 years) Source
- Phenotype characterisedPresent
22 HPO annotations (e.g. Skin rash; Arthritis; Joint swelling) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationPartial
2 EMA designations (none yet with FDA orphan-indication approval) — e.g. givinostat Source
- Interventional trialPresent
8 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
22
Associated phenotypes · MONDO:0019434
- Skin rash
- Arthritis
- Joint swelling
- Autoimmunity
- Elevated erythrocyte sedimentation rate
Showing 5 of 22 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
2
Designations · no FDA orphan-indication approval yet
- EMA givinostatTreatment of systemic-onset juvenile idiopathic arthritis · 28/01/2010 · WithdrawnEMA designation
- EMA recombinant human monoclonal antibody to human IL-1beta of the IgG1/K classTreatment of systemic-onset juvenile idiopathic arthritis · 05/02/2008 · WithdrawnEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
11
Drugs / clinical candidates · MONDO_0019434
- ANAKINRA·phase 3
- BARICITINIB·phase 3
- CANAKINUMAB·phase 3
- TOCILIZUMAB·phase 3
- TOFACITINIB·phase 3
- UPADACITINIB·phase 3
- EMAPALUMAB·phase 2
- GIVINOSTAT·phase 2
- MAS-825·phase 2
- RILONACEPT·phase 2
- SARILUMAB·phase 2
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
3,163
3,163 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,163 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,801 in the last 10 years · medium confidence · 90.2th percentile (publications denominator)
Phrase hits: 3,154 · MeSH hits: 9
Who's working on it?
1,122
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Horneff G5 papers · 2026
German Center for Paediatric and Adolescent Rheumatology , Garmisch-Partenkirchen , Germany.
Papers in Europe PMC - 02Koné-Paut I5 papers · 2023
Division of Pediatric Rheumatology, Bicêtre Hospital, APHP, University of Paris SUD, 78 rue du Général Leclerc, Le Kremlin-Bicêtre, Cedex, 94270, France.
Papers in Europe PMC - 03Belot A4 papers · 2025
Pediatric Nephrology, Rheumatology, Dermatology Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, 69677 Bron, France.
Papers in Europe PMC - 04Chaussabel D4 papers · 2025
Systems Immunology, Benaroya Research Institute, Seattle, WA, USA. dchaussabel@sidra.org.
Papers in Europe PMC - 05de Jager W4 papers · 2018
Dept. of Pediatric Immunology, University Medical Center Utrecht, Utrecht, the Netherlands
Papers in Europe PMC - 06Rinchai D4 papers · 2025
Research Branch, Sidra Medicine, Doha, Qatar. drinchai@sidra.org.
Papers in Europe PMC - 07
- 08Zhang Y4 papers · 2026
Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China.
Papers in Europe PMC - 09Abdwani R3 papers · 2025
Department of Child Health, Sultan Qaboos University Hospital, University Medical City, Muscat, Oman.
Papers in Europe PMC - 10Aggarwal A3 papers · 2023
Department of Clinical Immunology and Rheumatology, SGPGIMS, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raibareli Road, Lucknow, 226014, India. aa.amita@gmail.com.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
8
interventional trials for this specific condition
8 interventional trials matched this specific condition name; 1 currently recruiting in our sample. 172 trials are registered for juvenile idiopathic arthritis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
8 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 91.5th percentile).
medium confidence · 91.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
8 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07625384·NOT YET RECRUITING·Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease
Not reviewed·Conditions: Still Disease·Matched via name phrase
Broader category: juvenile idiopathic arthritis
172
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07184450·RECRUITING·Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Not reviewed·Conditions: Juvenile Dermatomyositis (JDM) · Polyarticular Juvenile Idiopathic Arthritis · Systemic Sclerosis (SSc) · Primary Sjogren's Syndrome·Matched via name phrase
- NCT07386587·ENROLLING BY INVITATION·Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT05984758·NOT YET RECRUITING·Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Uveitis, Anterior · Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT02991469·RECRUITING·A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT06376149·RECRUITING·M3-JIA: Making Mindfulness Matter for Children With JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis · Children · Mental Health · Mental Well-being·Matched via name phrase
- NCT06184100·RECRUITING·Virtual Self-Management Program for JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07553182·RECRUITING·OLE Study With Filgotinib in JIA
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT06888973·ENROLLING BY INVITATION·Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Not reviewed·Conditions: Rheumatoid Arthritis · Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Ankylosing Spondylitis (AS)·Matched via name phrase
- NCT07634354·NOT YET RECRUITING·Sarcopenia and Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT06618937·NOT YET RECRUITING·Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07217782·RECRUITING·Pain in Juvenile Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07234747·RECRUITING·Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07661069·NOT YET RECRUITING·YOGA FOR CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA)·Matched via name phrase
- NCT07554495·RECRUITING·Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
Not reviewed·Conditions: Polyarticular Course Juvenile Idiopathic Arthritis·Matched via name phrase
- NCT07087912·RECRUITING·Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Not reviewed·Conditions: Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE) · Juvenile Systemic Lupus Erythematosus·Matched via name phrase
Observational and natural-history studies
13 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07077304·RECRUITING·EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Not reviewed·Conditions: Myocarditis · ANCA Associated Vasculitis · Pericarditis · Systemic Sclerosis·Matched via name phrase
- NCT05200715·RECRUITING·AutoInflammatory Disease Alliance Registry (AIDA)
Not reviewed·Conditions: Hereditary Autoinflammatory Diseases · Schnitzler Syndrome · Behcet Syndrome · PFAPA Syndrome·Matched via name phrase
- NCT07126145·NOT YET RECRUITING·Clinical Autoinflammatory Disease Cohort
Not reviewed·Conditions: Still Disease · Autoinflammatory Disease·Matched via name phrase
- NCT04402086·RECRUITING·Rheumatology Patient Registry and Biorepository
Not reviewed·Conditions: Rheumatic Diseases · Adult Onset Still Disease · Ankylosing Spondylitis · Psoriatic Arthritis·Matched via name phrase
- NCT05927454·RECRUITING·Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
Not reviewed·Conditions: Still Disease · Still's Disease, Adult-Onset · Still Disease, Juvenile Onset·Matched via name phrase
- NCT07517250·RECRUITING·A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Not reviewed·Conditions: Familial Mediterranean Fever · Still Disease · Systemic Juvenile Idiopathic Arthritis · Adult-Onset Still Disease·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 41 · after dedupe 41 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 41 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (41)
- isrctn·ISRCTN95363507·No longer recruiting·Tocilizumab in anti-TNF refractory patients with juvenile idiopathic arthritis (JIA) associated uveitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74144960·Not yet recruiting·Can metformin reduce heart muscle thickening and improve exercise capacity in people with heart failure with preserved ejection fraction who are overweight or have insulin resistance?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN87496737·No longer recruiting·Influence of a very low-carbohydrate diet on the body's responses and adaptations to intense exercise in healthy young adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN25686858·Recruiting·Effect of evidence-driven computerised rule-guided exercise prescription combined with closed-loop remote supervision
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16284357·No longer recruiting·Effects of a 24-week block-based versus circuit-based exercise program in overweight and obese Chilean adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15345654·Not yet recruiting·A pilot study investigating the benefits of a new form of nutritional supplement called “immuno-nutrition” on muscle mass and strength in people on haemodialysis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98767603·Recruiting·Rehabilitation enhancing support for therapeutic orthosis and rehabilitation efforts
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10621395·Recruiting·CAR-T cells for children with CNS tumours
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12291894·Recruiting·Investigating strength training exercise prior to surgery in patients with gullet and stomach cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15729514·Recruiting·Using advanced MRI scans and muscle function tests to study muscle changes in adults with Pompe disease receiving enzyme replacement therapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13981390·Not yet recruiting·Evaluation of the use of dried blood samples for the detection of the 4-doping product vadadustat (Vafseo®)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16318269·Recruiting·Does a gentler root-cleaning method using air-polishing (Guided Biofilm Therapy) work as well as conventional instruments during periodontal surgery?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN38724906·Not yet recruiting·Plant Your Health: a randomised controlled trial comparing vegan, vegetarian and omnivorous diets in younger to middle-aged adults with overweight or obesity
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26393895·Recruiting·Effects of electronic cigarettes and traditional cigarettes on brain structures
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66242439·Recruiting·Examining the clinical effectiveness, feasibility and acceptability of intra-apheresis cycling for peripheral blood stem cell donations
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95632340·No longer recruiting·Can a protein-mineral drink support bone and muscle health in young basketball players?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN89448306·Recruiting·Investigating infection risk and the microbiome in blood cancer patients treated with CD19 CAR-T therapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10469927·No longer recruiting·Can a 6-day guided hiking and mindfulness programme in biodiverse Alpine landscapes improve wellbeing and reduce rumination in older adults?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN58623135·No longer recruiting·Exercise programmes during compulsory substance use rehabilitation in men: a 6-month study of muscle mass, bone status, body fat, and heart rate variability
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12373430·Recruiting·QuicDNA Max Research Programme – multi site, multi-centre, non-interventional, biomarker platform study. Assessing blood based ctDNA (circulating tumour) testing to guide cancer care across multiple cancer types
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15571034·Recruiting·Exploring communication between people living with Motor Neurone Disease and their close persons with healthcare professionals
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12586238·Recruiting·Using a swallowable blood detection capsule to help triage patients presenting with symptoms of an upper gastrointestinal bleed
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN27020370·No longer recruiting·Can we predict advanced lymph node disease and safely avoid sentinel lymph node biopsy in early breast cancer? A nationwide study using Swedish registry data
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN89355835·Not yet recruiting·The SAFE study: Exploring a new support package for autistic children and their families
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN22165252·No longer recruiting·TinnSpire: Personalised vagus nerve & sound stimulation for the treatment of tinnitus
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Systemic-onset juvenile idiopathic arthritis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Systemic-onset juvenile idiopathic arthritis" OR "Still disease" OR "Systemic-onset JIA" OR "SoJIA" OR "systemic polyarthritis"
MeSH descriptor terms unioned into the query: Rheumatoid Arthritis, Systemic Juvenile
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Systemic-onset juvenile idiopathic arthritis" OR "Still disease" OR "Systemic-onset JIA" OR "SoJIA" OR "systemic polyarthritis" OR "Rheumatoid Arthritis, Systemic Juvenile"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 8 interventional · 13 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"juvenile idiopathic arthritis"
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: sJIA
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T03:00:24.695Z
